The U.S. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, the Institute for Clinical and Economic Review, an influential drug pricing body, said in a report Thursday.
Report: DOJ Weighs Settling Trump IRS Leak Case
Maggio 14, 2026
The Department of Justice is weighing whether to settle President Donald Trump’s $10 billion lawsuit against the IRS stemming from the leak of his tax
